摘要
目的为我国药品流通模式改革提供参考。方法简述美国的药品流通模式,并与我国进行比较,提出我国药品流通模式改革的难点及方向。结果与结论我国药品流通模式改革须慎重,政府应处理好各利益集团的关系,逐步建立医疗机构补偿机制,以利于改革的顺利进行。
OBJECTIVE: To provide references for Chinese drug distribution reform. METHODS: The drug distribution model in USA was briefly introdnced and compared with that in China. The difficulties and orientations in Chinese drug distribution reform were put forward. RESULTS & CONCLUSIONS: Drug distribution reform should be carried out cautiously. Our government should deal well with the relationships between different interested parties and set up a reimbursement mechanism in medical institutions in order to facilitate the reform.
出处
《中国药房》
CAS
CSCD
北大核心
2006年第22期1687-1689,共3页
China Pharmacy
关键词
药品
流通模式
药品福利管理机构
Drug
Distribution mode
Drug welfare control agency